Aptar Pharma Electronic Lockout Device Approved by EMA

Aptar Pharma, a world leader in innovative drug delivery systems, is pleased to announce the approval by the EMA of the first integrated electronic nasal lockout device (e-Lockout) following a multi-year development with Takeda Pharmaceuticals International AG..

InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery

InMed Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies announced the filing of a provisional patent application in the United States.

Research reveals manufacturers and contract packagers may miss serialization deadlines

New industry research reveals that more than one third (36 per cent) of pharmaceutical manufacturers and contract packagers are not currently preparing for global serialization requirements, despite impending deadlines.

Enhancing process safety and efficiency in the pharmaceutical industry with check Weighing solutions

A look at how pharmaceutical manufacturers can benefit from the use of dynamic checkweighing technology to comply with international standards, increase process safety, productivity and process...

The Arrival of Quality by Design in Logistics

Quality by Design (QbD) is a concept that has become mainstream in the pharmaceutical manufacturing space in recent years.QbD is a science- and risk-based approach to quality...

AstraZeneca significantly reduces the risk of disease in the Phase III PACIFIC trial for lung cancer

AstraZeneca and MedImmune, its global biologics research and development arm announced positive results for the Phase III PACIFIC trial, a randomised.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com